Yahoo Finance • 20 days ago

Insider trades: Intel, Bank of America, and Pinterest among notable names

A weekly overview of insider trading, highlighting significant purchases and sales by investors, directors, and executives. The transactions occurred between May 4, 2026, and May 8, 2026. * Intel (INTC [https://seekingalpha.com/symbol/I... Full story

Yahoo Finance • 23 days ago

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 24 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acke... Full story

Yahoo Finance • 28 days ago

Trending stocks this week as Big Tech earnings lift markets amid Fed pause

The stock market ended the week higher as investors worked through a wave of strong Big Tech earnings, while also navigating a divided Federal Reserve stance and renewed uncertainty in global oil markets. The Federal Reserve held its poli... Full story

Yahoo Finance • 28 days ago

Organon (OGN)’s Investors React Strongly as Sun Pharma Bets Big on Specialty Drug Expansion

After surging 119.70% so far in April, Organon & Co. (NYSE:OGN) secures a spot on our list of the mid-cap stocks with the highest gains in April.Organon (OGN)’s Investors React Strongly as Sun Pharma Bets Big on Specialty Drug Expansion A... Full story

Yahoo Finance • 29 days ago

Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates

Pharmaceutical company Organon (NYSE:OGN) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 3.5% year on year to $1.46 billion. Its non-GAAP profit of $0.71 per share was 16.8% below analysts’ consensus estimates.... Full story

Yahoo Finance • last month

Micron initiated, Rambus downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Baird upgraded Old Dominion(ODFL) to Ne... Full story

Yahoo Finance • last month

Organon & Co. (OGN) Soars to 52-Week High on $11.75-Billion Sun Merger

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Racking Up Monster Gains. Organon soared to a new 52-week high on Monday, as investors gobbled up shares after the company officially confirmed its planned $11.75-billion merger with Sun Ph... Full story

Yahoo Finance • last month

Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • last month

Tech Earnings Optimism Powers Stocks Higher

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.12%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.13%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.01%.  June E-mini S&P futures (ESM26) rose +0.14%, and June E... Full story

Yahoo Finance • last month

Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

Organon(NYSE:OGN), a women’s health therapies specialist, closed Monday at $13.16, up 16.87%. The stock is jumping after premarket news that Sun Pharmaceutical Industries agreed to acquire Organon in an all-cash deal. Trading volume reache... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks fell late Monday afternoon with the NYSE Health Care Index easing 0.2% and the St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks were lower Monday afternoon with the NYSE Health Care Index easing 0.1% and the S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Stocks Slip as Higher Oil Prices Spur Inflation Concerns

The S&P 500 Index ($SPX) (SPY) today is down -0.12%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%.  June E-mini S&P futures (ESM26) are down -0.14%, and June E-mini Na... Full story

Yahoo Finance • last month

Shell acquiring Arc for $13.6B, China blocks Meta's bid for Manus AI

Yahoo Finance Senior Producer John Hyland tracks today's top moving stocks and biggest market stories in this Market Minute, including Shell's (SHEL) plans to acquire Arc Resources (ARX.TO), Sun Pharmaceuticals buying Organon (OGN) for nea... Full story

Yahoo Finance • last month

Sun Pharma Joins the Big Table With Organon Acquisition

Sun Pharma Joins the Big Table With Organon Acquisition - Moby THE GIST Sun Pharmaceuticals will acquire New Jersey-based Organon & Co in an all-cash deal valued at $11.75 billion (plus debt), in the largest overseas acquisition made by... Full story

Yahoo Finance • last month

Stocks Pressured by Higher Oil Prices

The S&P 500 Index ($SPX) (SPY) today is unchanged, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.10%.  June E-mini S&P futures (ESM26) are down -0.02%, and June E-mini Nasdaq... Full story

Yahoo Finance • last month

Organon Stock Soars. It’s Riding the Pharma M&A Wave as Sun Seals Takeover.

India’s Sun Pharmaceutical Industries agrees to buy the women’s health company for $14 a share in an all-cash deal. Continue Reading... Full story

Yahoo Finance • last month

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • last month

Stocks Mostly Down Pre-Bell as Iran Reportedly Offers New Proposal to Open Strait of Hormuz

The benchmark US stock measures were mostly tracking in the red before the opening bell Monday as tr PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story